FCM
RMD icon

Frontier Capital Management’s ResMed RMD Stock Holding History

Frontier Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6M Sell
65,224
-10,284
-14% -$2.56M 0.15% 195
2025
Q4 		$18.2M Sell
75,508
-81,360
-52% -$20.8M 0.19% 179
2025
Q3 		$42.9M Sell
156,868
-24,668
-14% -$6.74M 0.38% 89
2025
Q2 		$46.8M Sell
181,536
-11,409
-6% -$2.72M 0.43% 90
2025
Q1 		$43.2M Buy
192,945
+666
+0.3% +$155K 0.47% 72
2024
Q4 		$44M Buy
192,279
+45,075
+31% +$10.9M 0.42% 88
2024
Q3 		$35.9M Sell
147,204
-3,879
-3% -$867K 0.34% 120
2024
Q2 		$28.9M Buy
151,083
+23,635
+19% +$4.8M 0.29% 137
2024
Q1 		$25.2M Buy
+127,448
New +$23.4M 0.24% 148
2023
Q3 		– Sell
-189,454
Closed -$41.4M – 273
2023
Q2 		$41.4M Buy
189,454
+119,673
+171% +$26.7M 0.4% 91
2023
Q1 		$15.3M Buy
69,781
+3,574
+5% +$775K 0.16% 166
2022
Q4 		$13.8M Sell
66,207
-2,140
-3% -$470K 0.15% 181
2022
Q3 		$14.9M Sell
68,347
-3,549
-5% -$808K 0.17% 168
2022
Q2 		$15.1M Sell
71,896
-8,270
-10% -$1.76M 0.17% 172
2022
Q1 		$19.4M Sell
80,166
-12,549
-14% -$3.04M 0.18% 170
2021
Q4 		$24.1M Sell
92,715
-13,899
-13% -$3.61M 0.19% 159
2021
Q3 		$28.1M Sell
106,614
-8,531
-7% -$2.33M 0.22% 145
2021
Q2 		$28.4M Sell
115,145
-14,999
-12% -$3.15M 0.21% 162
2021
Q1 		$25.3M Sell
130,144
-96,710
-43% -$19.4M 0.19% 155
2020
Q4 		$48.2M Sell
226,854
-75,629
-25% -$15.1M 0.36% 106
2020
Q3 		$51.9M Sell
302,483
-90,850
-23% -$16.8M 0.45% 79
2020
Q2 		$75.5M Sell
393,333
-21,516
-5% -$3.52M 0.67% 46
2020
Q1 		$61.1M Sell
414,849
-23,316
-5% -$3.71M 0.69% 46
2019
Q4 		$67.9M Sell
438,165
-4,701
-1% -$678K 0.5% 71
2019
Q3 		$59.8M Buy
+442,866
New +$58M 0.47% 76

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Frontier Capital Management's RMD Position: Q1 2026 in Review

Frontier Capital Management reduced its ResMed (RMD) stake by 14% in Q1 2026, selling an estimated $2.56M and leaving 65,224 shares worth $14.6M. The position accounts for 0.15% of the portfolio, ranked #195.

Frontier Capital Management first reported a position in RMD in Q3 2019 and has held it in 25 quarters since. The position peaked at $75.5M in Q2 2020. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Frontier Capital Management held 65,224 shares of ResMed worth $14.6M as of Q1 2026.
  • Frontier Capital Management sold 10,284 ResMed shares in Q1 2026, an estimated $2.56M.
  • ResMed made up 0.15% of Frontier Capital Management's portfolio in Q1 2026, its #195 holding.
  • Frontier Capital Management first reported a position in ResMed in Q3 2019 and has held it in 25 quarters since.
  • Frontier Capital Management's ResMed position peaked at $75.5M in Q2 2020.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.